Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 3,425 | 8,922 | 2,823 | 3,702 | 3,942 |
| Gross Profit | 3,425 | 8,922 | 2,823 | 3,702 | 3,942 |
| Operating Expenses | 20,217 | 18,752 | 22,029 | 30,544 | 20,623 |
| Operating Income | -16,792 | -9,830 | -19,206 | -26,842 | -16,681 |
| Other Income | 160 | 219 | 238 | 243 | 187 |
| Pre-tax Income | -16,632 | -9,611 | -18,968 | -26,599 | -16,494 |
| Income Tax | N/A | 13 | -3 | -24 | N/A |
| Net Income Continuous | -16,632 | -9,624 | -18,965 | -26,575 | -16,494 |
| Net Income | $-16,632 | $-9,624 | $-18,965 | $-26,575 | $-16,494 |
| EPS Basic Total Ops | -0.23 | -0.14 | -0.27 | -0.38 | -0.23 |
| EPS Basic Continuous Ops | -0.23 | -0.14 | -0.27 | -0.38 | -0.23 |
| EPS Diluted Total Ops | -0.23 | -0.14 | -0.27 | -0.38 | -0.23 |
| EPS Diluted Continuous Ops | -0.23 | -0.14 | -0.27 | -0.38 | -0.23 |
| EBITDA(a) | $-16,431 | $-9,516 | $-18,928 | $-26,533 | $-16,364 |